YOU DESERVE BRAVE SCIENCE Trademark

Trademark Overview


On Wednesday, August 4, 2021, a trademark application was filed for YOU DESERVE BRAVE SCIENCE with the United States Patent and Trademark Office. The USPTO has given the YOU DESERVE BRAVE SCIENCE trademark a serial number of 90979850. The federal status of this trademark filing is REGISTERED as of Tuesday, September 12, 2023. This trademark is owned by Neurocrine Biosciences, Inc.. The YOU DESERVE BRAVE SCIENCE trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing medical information; providing medical information in the field of psychiatric, neurological, endocrine, central nervous system, hormonal, genetic and movement diseases, disorders and conditions; on-line information services, namely, providing medical information in the field of psychiatric, neurological, endocrine, central nervous system, hormonal, genetic and movement diseases, disorders and conditions

Research and development services in the fields of pharmaceuticals and biotechnology; pharmaceutical drug development services in the field of psychiatric, neurological, endocrine, central nervous system, hormonal, genetic and movement diseases, disorders and conditions
you deserve brave science

General Information


Serial Number90979850
Word MarkYOU DESERVE BRAVE SCIENCE
Filing DateWednesday, August 4, 2021
Status700 - REGISTERED
Status DateTuesday, September 12, 2023
Registration Number7165129
Registration DateTuesday, September 12, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2022

Trademark Statements


Goods and ServicesProviding medical information; providing medical information in the field of psychiatric, neurological, endocrine, central nervous system, hormonal, genetic and movement diseases, disorders and conditions; on-line information services, namely, providing medical information in the field of psychiatric, neurological, endocrine, central nervous system, hormonal, genetic and movement diseases, disorders and conditions
Goods and ServicesResearch and development services in the fields of pharmaceuticals and biotechnology; pharmaceutical drug development services in the field of psychiatric, neurological, endocrine, central nervous system, hormonal, genetic and movement diseases, disorders and conditions

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 29, 2021
Primary Code042
First Use Anywhere DateMonday, January 3, 2022
First Use In Commerce DateMonday, January 3, 2022

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 29, 2021
Primary Code044
First Use Anywhere DateMonday, January 3, 2022
First Use In Commerce DateMonday, January 3, 2022

Trademark Owner History


Party NameNeurocrine Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Wednesday, May 4, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 7, 2021NEW APPLICATION ENTERED
Wednesday, September 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 3, 2022ASSIGNED TO EXAMINER
Wednesday, May 18, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 7, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 7, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 2, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 1, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, February 1, 2023TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, February 1, 2023DIVISIONAL REQUEST RECEIVED
Wednesday, February 1, 2023USE AMENDMENT FILED
Monday, March 6, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 25, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 19, 2023DIVISIONAL PROCESSING COMPLETE
Friday, May 19, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 8, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 9, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 12, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 12, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, February 20, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 20, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 20, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 20, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 20, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 20, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 20, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 20, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, January 22, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 22, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED